
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8375504
[patent_doc_number] => 08258296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Crystalline antifungal compounds'
[patent_app_type] => utility
[patent_app_number] => 12/970297
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 28
[patent_no_of_words] => 32425
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12970297
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/970297 | Crystalline antifungal compounds | Dec 15, 2010 | Issued |
Array
(
[id] => 6214223
[patent_doc_number] => 20110136828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'SUBSTITUTED N-OXIDE PYRAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/968958
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4905
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136828.pdf
[firstpage_image] =>[orig_patent_app_number] => 12968958
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/968958 | Substituted N-oxide pyrazine derivatives | Dec 14, 2010 | Issued |
Array
(
[id] => 6084864
[patent_doc_number] => 20110144324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'METHODS AND COMPOSITIONS COMPRISING MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 12/967805
[patent_app_country] => US
[patent_app_date] => 2010-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19939
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144324.pdf
[firstpage_image] =>[orig_patent_app_number] => 12967805
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/967805 | METHODS AND COMPOSITIONS COMPRISING MACROCYCLES | Dec 13, 2010 | Abandoned |
Array
(
[id] => 8214339
[patent_doc_number] => 08193190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/966413
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10998
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193190.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966413
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966413 | Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors | Dec 12, 2010 | Issued |
Array
(
[id] => 8477801
[patent_doc_number] => 20120277208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'BENZAMIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/513667
[patent_app_country] => US
[patent_app_date] => 2010-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36143
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/513667 | BENZAMIDE COMPOUND | Dec 8, 2010 | Abandoned |
Array
(
[id] => 6128627
[patent_doc_number] => 20110087022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Dipeptidyl Peptidase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/964410
[patent_app_country] => US
[patent_app_date] => 2010-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33461
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20110087022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12964410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/964410 | Dipeptidyl peptidase inhibitors | Dec 8, 2010 | Issued |
Array
(
[id] => 6142167
[patent_doc_number] => 20110129463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/954793
[patent_app_country] => US
[patent_app_date] => 2010-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9932
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129463.pdf
[firstpage_image] =>[orig_patent_app_number] => 12954793
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954793 | Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof | Nov 25, 2010 | Abandoned |
Array
(
[id] => 5977664
[patent_doc_number] => 20110071074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'DEUTERATED HEPATITIS C PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/953876
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12438
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12953876
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953876 | Deuterated hepatitis C protease inhibitors | Nov 23, 2010 | Issued |
Array
(
[id] => 6163251
[patent_doc_number] => 20110160217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'DEUTERIUM ENRICHED ANALOGUES OF TADALAFIL AS PDE5 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/954591
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21733
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12954591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954591 | DEUTERIUM ENRICHED ANALOGUES OF TADALAFIL AS PDE5 INHIBITORS | Nov 23, 2010 | Abandoned |
Array
(
[id] => 5978088
[patent_doc_number] => 20110071167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)'
[patent_app_type] => utility
[patent_app_number] => 12/952425
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19106
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071167.pdf
[firstpage_image] =>[orig_patent_app_number] => 12952425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952425 | METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) | Nov 22, 2010 | Abandoned |
Array
(
[id] => 6186617
[patent_doc_number] => 20110124673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => '6-ALKENYL AND 6-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/950345
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23687
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124673.pdf
[firstpage_image] =>[orig_patent_app_number] => 12950345
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/950345 | 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors | Nov 18, 2010 | Issued |
Array
(
[id] => 6000965
[patent_doc_number] => 20110117214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/946529
[patent_app_country] => US
[patent_app_date] => 2010-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11377
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12946529
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/946529 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | Nov 14, 2010 | Abandoned |
Array
(
[id] => 6007905
[patent_doc_number] => 20110059936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'C-MET PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/942395
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74408
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059936.pdf
[firstpage_image] =>[orig_patent_app_number] => 12942395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/942395 | c-MET protein kinase inhibitors | Nov 8, 2010 | Issued |
Array
(
[id] => 6026316
[patent_doc_number] => 20110053963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'TARTRATE SALTS OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY'
[patent_app_type] => utility
[patent_app_number] => 12/941812
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 40702
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053963.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941812
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941812 | TARTRATE SALTS OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY | Nov 7, 2010 | Abandoned |
Array
(
[id] => 6054530
[patent_doc_number] => 20110110890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Novel Inhibitors of Hepatitis C Virus Replication'
[patent_app_type] => utility
[patent_app_number] => 12/941682
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39042
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110890.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941682
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941682 | Novel Inhibitors of Hepatitis C Virus Replication | Nov 7, 2010 | Abandoned |
Array
(
[id] => 9047026
[patent_doc_number] => 08541580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Process for the preparation of pyrazinone thrombin inhibitor and its intermediates'
[patent_app_type] => utility
[patent_app_number] => 12/938297
[patent_app_country] => US
[patent_app_date] => 2010-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3568
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12938297
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/938297 | Process for the preparation of pyrazinone thrombin inhibitor and its intermediates | Nov 1, 2010 | Issued |
Array
(
[id] => 5945125
[patent_doc_number] => 20110105745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'COMPOSITIONS AND METHODS OF MAKING A PHOTOACTIVE AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/917353
[patent_app_country] => US
[patent_app_date] => 2010-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6854
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105745.pdf
[firstpage_image] =>[orig_patent_app_number] => 12917353
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/917353 | Compositions and methods of making a photoactive agent | Oct 31, 2010 | Issued |
Array
(
[id] => 5986792
[patent_doc_number] => 20110098263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/913398
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6448
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12913398
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913398 | Hydroxy-substituted gold(III) porphyrin complexes as histone deacetylase inhibitors | Oct 26, 2010 | Issued |
Array
(
[id] => 8146772
[patent_doc_number] => 08163766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Beta-secretase modulators and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/909566
[patent_app_country] => US
[patent_app_date] => 2010-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73361
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163766.pdf
[firstpage_image] =>[orig_patent_app_number] => 12909566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/909566 | Beta-secretase modulators and methods of use | Oct 20, 2010 | Issued |
Array
(
[id] => 5987249
[patent_doc_number] => 20110098313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'POSITIVE ALLOSTERIC MODULATORS (PAM)'
[patent_app_type] => utility
[patent_app_number] => 12/908014
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9843
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098313.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908014 | Positive allosteric modulators (PAM) | Oct 19, 2010 | Issued |